title: What Is Reasonably Foreseeable? Lessons Learned From the SUPPORT Trial.
authors.affiliation: Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia. Electronic address: daniel.trifiletti@gmail.com.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Trifiletti
authors.affiliation: Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia.
authors.forename: Timothy N
authors.initials: TN
authors.lastname: Showalter
authors.affiliation: Center for Biomedical Ethics and Humanities, University of Virginia, Charlottesville, Virginia.
authors.forename: Lois
authors.initials: L
authors.lastname: Shepherd
mesh_terms: D057186:Comparative Effectiveness Research; D032962:Consent Forms / Q000592:standards*; D006801:Humans; D062071:Infant, Extremely Premature; D007231:Infant, Newborn; D008297:Male; D015337:Multicenter Studies as Topic; D010100:Oxygen / Q000008:administration & dosage / Q000009:adverse effects; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects* / Q000401:mortality / Q000592:standards; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D011897:Random Allocation; D016032:Randomized Controlled Trials as Topic; D012178:Retinopathy of Prematurity / Q000209:etiology; D016896:Treatment Outcome; D014342:Truth Disclosure; D035501:Uncertainty; D014481:United States; D018172:United States Office of Research Integrity / Q000592:standards*
chemical_list: D010100:Oxygen